ArticleFrontiers in oncology2022

A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer.

Renhong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.